Buys | $0 | 0 | 0 |
Sells | $8,430,175 | 4 | 100 |
WHITE MICHAEL ANTHONY | Chief Scientific Officer | 0 | $0 | 1 | $1.03M | $-1.03M |
Hata Yujiro S | President and CEO | 0 | $0 | 3 | $7.4M | $-7.4M |
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers …
Over the last 12 months, insiders at IDEAYA Biosciences, Inc. have bought $0 and sold $8.43M worth of IDEAYA Biosciences, Inc. stock.
On average, over the past 5 years, insiders at IDEAYA Biosciences, Inc. have bought $3.45M and sold $11.67M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,062 shares for transaction amount of $67,408 was made by BVF PARTNERS L P/IL (10 percent owner) on 2020‑06‑30.
2024-05-29 | Sale | WHITE MICHAEL ANTHONY | Chief Scientific Officer | 28,500 0.038% | $36.24 | $1.03M | -15.37% | |
2024-05-16 | Sale | Hata Yujiro S | President and CEO | 34,433 0.0453% | $41.81 | $1.44M | -26.51% | |
2024-05-15 | Sale | Hata Yujiro S | President and CEO | 83,856 0.112% | $42.90 | $3.6M | -28.04% | |
2024-05-14 | Sale | Hata Yujiro S | President and CEO | 56,711 0.0746% | $41.61 | $2.36M | -26.76% | |
2024-02-09 | Sale | Hata Yujiro S | President and CEO | 23,557 0.0351% | $45.54 | $1.07M | -18.78% | |
2024-02-09 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.003% | $46.02 | $92,045 | -18.78% | |
2024-02-08 | Sale | Hata Yujiro S | President and CEO | 75,815 0.1121% | $45.15 | $3.42M | -16.75% | |
2024-02-01 | Sale | Hata Yujiro S | President and CEO | 628 0.0009% | $45.00 | $28,260 | -15.63% | |
2024-01-22 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0028% | $42.03 | $84,050 | -10.78% | |
2024-01-16 | Sale | Hata Yujiro S | President and CEO | 62,739 0.0965% | $40.17 | $2.52M | -5.95% | |
2024-01-12 | Sale | Hata Yujiro S | President and CEO | 12,261 0.0191% | $40.04 | $490,913 | -3.55% | |
2024-01-12 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.003% | $38.01 | $76,026 | -3.55% | |
2023-12-15 | Sale | Hata Yujiro S | President and CEO | 75,000 0.1165% | $35.03 | $2.63M | +9.30% | |
2023-12-15 | Sale | Throne Jason | Chief Legal Officer | 10,000 0.0155% | $35.04 | $350,371 | +9.30% | |
2023-12-14 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0031% | $34.00 | $68,002 | +12.01% | |
2023-11-03 | Sale | Throne Jason | Chief Legal Officer | 5,163 0.0085% | $30.09 | $155,360 | +32.35% | |
2023-09-12 | Sale | Throne Jason | Chief Legal Officer | 1,000 0.0018% | $30.00 | $30,005 | +30.25% | |
2023-09-05 | Sale | Throne Jason | Chief Legal Officer | 1,737 0.0031% | $30.03 | $52,160 | +32.78% | |
2023-09-01 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0035% | $30.01 | $60,016 | +28.50% | |
2023-09-01 | Sale | Throne Jason | Chief Legal Officer | 2,100 0.0037% | $30.03 | $63,063 | +28.50% |
DIEKMAN JOHN D | director | 2844545 3.2495% | $52.85M | 1 | 0 | <0.0001% |
SHANNON TIMOTHY M | director | 2660713 3.0395% | $49.44M | 1 | 0 | <0.0001% |
CANAAN X L.P. | 10 percent owner | 2660713 3.0395% | $49.44M | 1 | 0 | <0.0001% |
Alexandria Venture Investments, LLC | 10 percent owner | 432384 0.4939% | $8.03M | 1 | 0 | <0.0001% |
BVF PARTNERS L P/IL | 233150 0.2663% | $4.33M | 3 | 1 | <0.0001% |
$8,217,280 | 112 | 46.33% | $1.29B | |
$831,902,292 | 108 | 9.34% | $1.58B | |
$20,297,544 | 73 | 103.06% | $1.61B | |
$1,101,324,300 | 58 | 37.37% | $1.3B | |
$11,583,737 | 45 | 49.75% | $1.75B |
Increased Positions | 129 | +64.5% | 11M | +11.46% |
Decreased Positions | 88 | -44% | 8M | -9.08% |
New Positions | 32 | New | 1M | New |
Sold Out Positions | 34 | Sold Out | 4M | Sold Out |
Total Postitions | 241 | +20.5% | 94M | +2.38% |
Fmr Llc | $266,652.00 | 14.73% | 12.96M | +327,498 | +2.59% | 2024-12-31 |
Blackrock, Inc. | $172,316.00 | 9.52% | 8.38M | +696,115 | +9.06% | 2024-12-31 |
Janus Henderson Group Plc | $120,492.00 | 6.66% | 5.86M | +695,263 | +13.47% | 2024-12-31 |
Vanguard Group Inc | $104,456.00 | 5.77% | 5.08M | +282,936 | +5.9% | 2024-12-31 |
Federated Hermes, Inc. | $104,157.00 | 5.75% | 5.06M | -144,774 | -2.78% | 2024-12-31 |
Price T Rowe Associates Inc /Md/ | $79,542.00 | 4.39% | 3.87M | -148,390 | -3.7% | 2024-12-31 |
State Street Corp | $68,311.00 | 3.77% | 3.32M | +2,962 | +0.09% | 2024-12-31 |
Logos Global Management Lp | $61,710.00 | 3.41% | 3M | +900,000 | +42.86% | 2024-12-31 |
Deerfield Management Company, L.P. (Series C) | $56,280.00 | 3.11% | 2.74M | +142,000 | +5.47% | 2024-12-31 |
Capital Research Global Investors | $52,781.00 | 2.92% | 2.57M | -459 | -0.02% | 2024-12-31 |